Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma

标题
Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma
作者
关键词
mesenchymal-epithelial transition inducer, MEK and SRC inhibitor combination treatment, PD0325901, saracatinib, non-small-cell lung cancer
出版物
Oncotarget
Volume 6, Issue 30, Pages -
出版商
Impact Journals, LLC
发表日期
2015-09-30
DOI
10.18632/oncotarget.5031

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started